Structure via PubChem · Public domain (PubChem)
omidenepag
Sign in to saveAlso known as UR-7276, UR 7276
Omidenepag, sold under the brand name Eybelis among others, is a medication used for the treatment of glaucoma and ocular hypertension.
Chemical data
- Formula
- C23H22N6O4S
- Molecular weight
- 478.5 g/mol
- IUPAC name
- 2-[[6-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]-2-pyridinyl]amino]acetic acid
- SMILES
- C1=CC(=NC(=C1)NCC(=O)O)CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4
- InChIKey
- YHGSTSNEOJUIRN-UHFFFAOYSA-N
- XLogP
- 1.8
- Polar surface area
- 139 Ų
- H-bond donors
- 2
- H-bond acceptors
- 9
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- glaucoma
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 478.1423241840001
Show 2 more facts
- canonical SMILES
- C1=CC(=NC(=C1)NCC(=O)O)CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4
- chemical formula
- C₂₃H₂₂N₆O₄S
Sources (1)
via Wikidata · CC0
~1 min read
Encyclopedic overview
6 sectionsContents
- Medical uses
- Adverse effects
- Pharmacology
- History
- References
- External links
Omidenepag, sold under the brand name Eybelis among others, is a medication used for the treatment of glaucoma and ocular hypertension.
Omidenepag was approved for medical use in Japan in 2018, and in the United States in September 2022.
Excerpted from Wikipedia’s “omidenepag” article, available under the CC BY-SA 4.0 licence.